FDA Issues Emergency Use Authorization for Anti-Coronavirus Drug Remdesivir
By Craig Bannister | May 1, 2020 | 5:23pm EDT
On Friday, the U.S. Food and Drug Administration FDA) issued an emergency use authorization (EUA) to Gilead Sciences Inc. for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
Clinical trials of the drug have yielded promising results, and there is no time to waste in trying to save lives threatened by the coronavirus, an FDA press release announcing the EUA:
https://cnsnews.com/index.php/blog/craig-bannister/fda-issues-emergency-use-authorization-anti-coronavirus-drug-remdesivir
